In vitro activities of benanomicins and their analogues against humanimmunodeficiencyvirus and fungi including Candida, Cryptococcus and Aspergillus, were examined. The free carboxyl group and at least one sugar moiety in the benanomicins were essential for their activities. Benanomicin A was most active and had low toxicity, and was selected as the best candidate for chemotherapy.
VOL. 44 NO. ll THE JOURNAL OF ANTIBIOTICS 1229
Methyl Esters A solution ofA (55.8mg) in 0.02n HCl-MeOH(50ml) was stirred at room temperature for 15hours and then concentrated to dryness. The residue was dissolved in 1 ml of DMSO and purified on a column of Sephadex LH-20 (Pharmacia AB, 500 ml) developed with MeOH.The reddish eluate was concentrated to yield 38.3mg of benanomicin A methyl ester (A-ME), mp >220°C, FAB-MSm/z 841 (M~). Benanomicin B methyl ester hydrochloride (B-ME) (45.3mg) was obtained from B (50.3mg) by a similar method to that described above. MP >200°C, FAB-MSm/z 840 (MT). Dexylosylbenanomicin A methyl ester (A-DXME) (77.9 mg) was obtained from A-DX (95.5 mg) by a similar method to that described above. MP >200°C, FD-MS m/z 709 (M+).
NMRdata of A-ME, B-MEand A-DXME are shown in Tables 1 and 2. 7V-Acetyl Derivatives To a solution ofB (125mg) in 0.1 m Na2CO3 (10ml) was added Ac2O (0.1ml) and the solution was NOV. 1991 stirred at room temperature for 20 minutes. The solution was adjusted to pH 4.0 with 1 n HC1and was passed through a column of Diaion HP-20 (Mitsubishi Chemical Ind., Ltd., 20ml) and after washing with water, the column was eluted with 80%aq acetone to yield a reddish powder. The powder was re-chromatographed by Sephadex LH-20 column (300ml) developed with MeOHto obtain 118mg of 7V-acetylbenanomicin B (B-AC) as a reddish powder. MP >200°C, SI-MS m/z 868 (M+). 7V-Acetyldexylosylbenanomicin B (B-DXAC) (31.5 mg) was obtained from B-DX (35.0 mg) by a similar method to that described above. MP>200°C, FAB-MSmjz 736 (M").
NMRdata ofB-AC and B-DXACare shown in Tables 1 and 2 .
Benanomicin A 4"'-Sulfate (A-SU) To a solution of A (free acid, 251mg) in anhydrous pyridine (5ml) was added sulfur trioxidetrimethylamine complex (SO3 -NMe3, 84mg). After warming at 50°C for 40 minutes, water (0.5ml) was added to the reaction mixture to decomposethe excess reagent. The solution was concentrated to give a solid, which was separated by centrifugal countercurrent partition chromatography (CPC Model NMF, Sanki Engineering) using the solvent system of BuOH-H2O-pyridine 
Antifungal Activities
MICs on a glucose-nutrient agar consisting of glucose 1.0%, peptone (Polypepton, Wako Pure Chemicals) 1.0%, meat extract (Kyokuto Seiyaku) 1.0%, NaCl 0.3% and agar (Kyoei Seiyaku) 2.0% (pH 7.0) were determined by the 2-fold agar dilution method after incubation at 27°C for 42 hours. The test organisms which were grown in Sabouraud bouillon mediumat 27°C for 2 days, were used for inoculation.
Anti-HIV Activities
A human T-cell line, MT-4 cells (1 x 105 cells/ml) in 0.5 ml of RPMI-1640 culture medium were seeded into 48-well plates, and test compounds in Ca2+ and Mg2+ free phosphate buffered saline (PBS) were added at concentrations of 100, 30, 10, 3 and 1 /xg/ml (compounds were dissolved in DMSOat lOmg/ml and the solution was diluted with PBS). Two hours later 50fA of the HTLV-IIIB strain ofHIV-1 (2.5 x 105 to 5 x 105 PFU/ml) was inoculated onto the cells. After 4 days, MT-4cells were smeared onto slide glasses, dried and fixed with acetone. The presence (%) of HIV antigen-positive cells were detected by the indirect immunofluorescence assay.9)
The effects of test compounds and DMSO on growth of uninfected MT-4cells were examined by counting viable cells using a dye exclusion method. MT-4cells were seeded at 2 x 105/ml and counted after cultivation for 4 days.5) Syncytium formation assay5) was performed as follows. Molt-4 human T-cells were seeded into Costar 48-well plates in an amount of 1 x 105 cells/well, and test compounds (50^1) were added. After 2 hours, Molt-4 cells persistently infected with HIV-1 were added at 1.5 x 104 cells/well. After cultivation for 24 hours, numbers of syncytia formed were counted using a microscope after fixation with 5%formalin.
Activated Partial Thromboplastin Time (APTT)
APTTof plasma from a normal subject was examined in the presence of test compoundsby using an automated machine. Platerin plus activator was obtained from OrganonTeknika Corporation (Durham). Human plasma (90^1) was mixed with platerin plus activator (100//I) and test compounds (10/il), and then APTTwas measured.10) Acute Toxicity LD50 were determined with five male Jcl : ICR mice (ca. 20 g weight) at each dose level. Test compounds in physiological saline or 10%DMSOaq soln (0.25 ml) were injected intravenously and mice were observed for14days. p Table 3 . In vitro antifungal activity on glucose-nutrient agar.
MIC (jig/ml)
A-ME A-DX A-DXME A-SU 
Results
Antifungal Activities As shown in Table 3 , A and B showed good in vitro antifungal activities against Candida, Saccharomyces, Cryptococcus and Aspergillus on glucose -nutrient agar medium.A-DXand B-DXhave also good activities: B-DXis more active than B against Candida, but not against Aspergillus. A-SUand B-AChave moderately active against yeasts and yeast like fungi. The methyl esters (A-ME, A-DXME,B-ME and B-DXME)and benanomicinone derivatives (AGL, AGL-MEand AGL-OM)were nearly inactive.
Anti-HIV Activities
As shown in Table 4 , A and B inhibited infection of HIV-1 at concentration of 10/ig/ml, but did not inhibit HIV reverse transcriptase (data are not shown). Growth of MT-4 cells ( Table 5 ) was affected by 100 /ig/ml of B-ME, B-DX, B-DXMEand DMSO. Although all sample solutions contained DMSO,we concluded that A and B had little or no effect on growth of cells at 100/ig/ml. As already reported,5) A and B also inhibited syncytium formation induced by HIV-1 at concentrations of 10~lOO^g/ml (Table 6 ). CT  < 1  >90  60  23  >90  >90  >90  >90  >90  >90  >90  >90  <1  53  >90  >90  >90   <   <   >9   1  CT  CT  CT  82  CT  > 90  1  85  80  24  >90  >90  >90  1  >90  >90  70  >90  >90  >90  3  >90  >90  >90  >90  >90  >90  0  >90  >90  >90  >90 CT: Cytotoxic. Solvent control. Table 6 . Effects on syncytium formation induced by HIV-1. Acute Toxicity As shown in Table 8 , compoundshaving a free amino group, B and B-DXshowed acute LD50 values (mice, iv) of 150 and 180mg/kg, respectively. However, compounds possessing no positive charge had very low toxicity. In particular, A was not toxic by iv injection of 600mg/kg.
Discussion
Studies on structure-activity relationships amongvarious analogues of benanomicins revealed that the carboxyl group and at least one sugar moiety were essential for antifungal and anti-HIV activities.
The important role of the free carboxyl group in the benanomicins was evident, because all ester derivatives had reduced activities. Interestingly, dexylosyl derivatives showed good activities against Candida and Cryptococcus, but decreased anti-Aspergillus and anti-HIV activities. A free amino group of B increased the acute toxicity in mice.
From the above-mentioned results, A, which has very low toxicity was selected as the best candidate not only for antifungal chemotherapy but also for anti-AIDS therapy. Because Candida, Cryptococcus and Aspergillus have been frequently detected in patients with AIDS, when A is used as an anti-HIV agent, the administration may be especially advantageous for patients with AIDSor AIDS-related complex who are infected with fungi or are at risk for fungal infection.
